SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-507474"
 

Search: onr:"swepub:oai:DiVA.org:uu-507474" > Prediction model fo...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Prediction model for drug response of acute myeloid leukemia patients

Trac, Quang Thinh (author)
Karolinska Institutet
Pawitan, Yudi (author)
Karolinska Institutet
Mou, Tian (author)
Shenzhen Univ, Sch Biomed Engn, Shenzhen, Peoples R China.
show more...
Erkers, Tom (author)
Karolinska Institutet
Östling, Päivi (author)
Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden.;Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland.
Bohlin, Anna (author)
Karolinska Univ, Karolinska Inst,Hosp Huddinge, Dept Med Huddinge, Unit Hematol, Stockholm, Sweden.
Österroos, Albin (author)
Uppsala universitet,Hematologi
Vesterlund, Mattias (author)
Karolinska Institutet
Jafari, Rozbeh (author)
Karolinska Institutet
Siavelis, Ioannis (author)
Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden.
Bäckvall, Helena (author)
Karolinska Institutet
Kiviluoto, Santeri (author)
Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden.
Orre, Lukas M. (author)
Karolinska Institutet
Rantalainen, Mattias (author)
Karolinska Institutet
Lehtiö, Janne (author)
Karolinska Institutet
Lehmann, Sören (author)
Uppsala universitet,Hematologi,Karolinska Univ, Karolinska Inst,Hosp Huddinge, Dept Med Huddinge, Unit Hematol, Stockholm, Sweden.
Kallioniemi, Olli (author)
Karolinska Institutet
Vu, Trung Nghia (author)
Karolinska Institutet
show less...
Karolinska Institutet Shenzhen Univ, Sch Biomed Engn, Shenzhen, Peoples R China (creator_code:org_t)
2023-03-24
2023
English.
In: npj Precision Oncology. - : Springer Nature. - 2397-768X. ; 7
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Despite some encouraging successes, predicting the therapy response of acute myeloid leukemia (AML) patients remains highly challenging due to tumor heterogeneity. Here we aim to develop and validate MDREAM, a robust ensemble-based prediction model for drug response in AML based on an integration of omics data, including mutations and gene expression, and large-scale drug testing. Briefly, MDREAM is first trained in the BeatAML cohort (n = 278), and then validated in the BeatAML (n = 183) and two external cohorts, including a Swedish AML cohort (n = 45) and a relapsed/refractory acute leukemia cohort (n = 12). The final prediction is based on 122 ensemble models, each corresponding to a drug. A confidence score metric is used to convey the uncertainty of predictions; among predictions with a confidence score >0.75, the validated proportion of good responders is 77%. The Spearman correlations between the predicted and the observed drug response are 0.68 (95% CI: [0.64, 0.68]) in the BeatAML validation set, -0.49 (95% CI: [-0.53, -0.44]) in the Swedish cohort and 0.59 (95% CI: [0.51, 0.67]) in the relapsed/refractory cohort. A web-based implementation of MDREAM is publicly available at https://www.meb.ki.se/shiny/truvu/MDREAM/.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view